Cantel Medical Corp. (CMD) Sets New 1-Year High at $100.79

Cantel Medical Corp. (NYSE:CMD)’s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $100.79 and last traded at $99.11, with a volume of 133600 shares. The stock had previously closed at $98.28.

CMD has been the topic of several research reports. Zacks Investment Research raised Cantel Medical Corp. from a “hold” rating to a “buy” rating and set a $83.00 price objective on the stock in a report on Tuesday, August 1st. Sidoti raised Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective on the stock in a report on Wednesday, August 2nd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cantel Medical Corp. in a report on Friday, September 1st. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $91.67.

The company has a market cap of $4,100.98, a P/E ratio of 47.25 and a beta of 1.23. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.41 and a quick ratio of 1.49.

Cantel Medical Corp. (NYSE:CMD) last announced its earnings results on Thursday, September 28th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.02. Cantel Medical Corp. had a net margin of 9.27% and a return on equity of 17.60%. The business had revenue of $205.50 million during the quarter, compared to the consensus estimate of $200.32 million. The company’s revenue for the quarter was up 14.8% compared to the same quarter last year. equities analysts anticipate that Cantel Medical Corp. will post 2.34 earnings per share for the current year.

The firm also recently announced a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Wednesday, January 17th will be paid a dividend of $0.085 per share. This is an increase from Cantel Medical Corp.’s previous Semi-Annual dividend of $0.07. The ex-dividend date of this dividend is Tuesday, January 16th. This represents a dividend yield of 0.17%. Cantel Medical Corp.’s dividend payout ratio is 8.19%.

In related news, EVP Eric W. Nodiff sold 2,868 shares of the firm’s stock in a transaction dated Friday, October 20th. The shares were sold at an average price of $97.55, for a total value of $279,773.40. Following the completion of the sale, the executive vice president now owns 39,102 shares in the company, valued at $3,814,400.10. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Chairman Charles M. Diker sold 20,500 shares of the firm’s stock in a transaction dated Wednesday, October 4th. The shares were sold at an average price of $99.15, for a total transaction of $2,032,575.00. The disclosure for this sale can be found here. Insiders have sold 36,368 shares of company stock valued at $3,576,028 in the last quarter. Insiders own 14.90% of the company’s stock.

A number of large investors have recently made changes to their positions in CMD. BlackRock Inc. acquired a new stake in Cantel Medical Corp. in the second quarter valued at about $376,271,000. Vanguard Group Inc. acquired a new stake in Cantel Medical Corp. in the second quarter valued at about $246,860,000. Neuberger Berman Group LLC acquired a new stake in Cantel Medical Corp. in the second quarter valued at about $96,236,000. Dimensional Fund Advisors LP acquired a new stake in Cantel Medical Corp. in the second quarter valued at about $75,756,000. Finally, Wells Fargo & Company MN acquired a new stake in Cantel Medical Corp. in the second quarter valued at about $75,715,000. Hedge funds and other institutional investors own 85.16% of the company’s stock.

WARNING: This news story was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this news story on another domain, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The legal version of this news story can be viewed at https://sportsperspectives.com/2017/11/14/cantel-medical-corp-cmd-sets-new-1-year-high-at-100-79.html.

Cantel Medical Corp. Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply